E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/3/2006 in the Prospect News Biotech Daily.

Theragenics amends, extends credit facility

New York, July 3 - Theragenics Corp. said it amended its $40 million credit facility with Wachovia Bank to extend the maturity to Oct. 30, 2009.

The amendment also changes some financial covenants. The requirements include: a ratio of senior liabilities to tangible net worth of not more than 0.5 to 1.0, a fixed charge coverage ratio of not less than 1.25 to 1.0, and liquid assets of at least $15 million through June 30, 2007, $17.5 million through June 30, 2008 and $20 million after that.

Interest is at Libor plus 100 basis points, according to an 8-K filing with the Securities and Exchange Commission.

Theragenics is a medical device company based in Buford, Ga., that manufactures brachytherapy and surgical products.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.